DK1272195T3 - Anvendelse af fulvestrant til behandling af resistent brystcancer - Google Patents

Anvendelse af fulvestrant til behandling af resistent brystcancer

Info

Publication number: DK1272195T3
Authority: DK; Denmark
Prior art keywords: fulvestrant; treatment; breast cancer; resistant breast; resistant
Prior art date: 2000-04-05

Application number

DK01917289T

Other languages

Danish (da)

English (en)

Inventor

Beat Thurlimann

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-05

Filing date

2001-04-02

Publication date

2006-01-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9889101&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1272195(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-04-02 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-01-16 Application granted granted Critical

2006-01-16 Publication of DK1272195T3 publication Critical patent/DK1272195T3/da

Links

206010006187 Breast cancer Diseases 0.000 title abstract 2
208000026310 Breast neoplasm Diseases 0.000 title abstract 2
VWUXBMIQPBEWFH-WCCTWKNTSA-N Fulvestrant Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC2=C1 VWUXBMIQPBEWFH-WCCTWKNTSA-N 0.000 title abstract 2
229960002258 fulvestrant Drugs 0.000 title abstract 2
229940095743 selective estrogen receptor modulator Drugs 0.000 abstract 2
239000000333 selective estrogen receptor modulator Substances 0.000 abstract 2
229940122815 Aromatase inhibitor Drugs 0.000 abstract 1
239000003886 aromatase inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK01917289T 2000-04-05 2001-04-02 Anvendelse af fulvestrant til behandling af resistent brystcancer DK1272195T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0008172.9A GB0008172D0 (en)	2000-04-05	2000-04-05	Therapy

Publications (1)

Publication Number	Publication Date
DK1272195T3 true DK1272195T3 (da)	2006-01-16

Family

ID=9889101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01917289T DK1272195T3 (da)	2000-04-05	2001-04-02	Anvendelse af fulvestrant til behandling af resistent brystcancer

Country Status (29)

Country	Link
US (2)	US20030158166A1 (es)
EP (2)	EP1272195B1 (es)
JP (1)	JP2003528919A (es)
KR (1)	KR100757764B1 (es)
CN (1)	CN1431905A (es)
AT (1)	ATE306270T1 (es)
AU (2)	AU2001244372B2 (es)
BR (1)	BR0109789A (es)
CA (1)	CA2403608A1 (es)
CH (1)	CH1272195H1 (es)
CZ (1)	CZ303096B6 (es)
DE (1)	DE60113975T2 (es)
DK (1)	DK1272195T3 (es)
EE (1)	EE05026B1 (es)
ES (1)	ES2248300T3 (es)
GB (1)	GB0008172D0 (es)
HK (1)	HK1051498A1 (es)
HU (1)	HU230064B1 (es)
IL (2)	IL151932A0 (es)
IS (1)	IS2869B (es)
MX (1)	MXPA02009744A (es)
NO (1)	NO329949B1 (es)
NZ (1)	NZ539603A (es)
PL (1)	PL201175B1 (es)
RU (1)	RU2265438C2 (es)
SK (1)	SK287779B6 (es)
UA (1)	UA80388C2 (es)
WO (1)	WO2001074366A1 (es)
ZA (1)	ZA200207538B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2453111A1 (en) *	2001-07-07	2003-01-23	Alan Marshall Irving	Pharmaceutical formulation for the intramuscular administration of fulvestrant
GB0116620D0 (en) *	2001-07-07	2001-08-29	Astrazeneca Ab	Formulation
EP1623713A1 (en) *	2004-07-09	2006-02-08	Proskelia SAS	Cominations of pure anti-estrogen with aromatase inhibitors
US8557863B2 (en) *	2005-09-27	2013-10-15	Robert Benson Aylor	Suppression and prevention of tumors
JP5256042B2 (ja) *	2005-11-22	2013-08-07	インサイト・コーポレイション	癌の処置のための併用療法
WO2007143600A2 (en) *	2006-06-05	2007-12-13	Incyte Corporation	Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
MX2013013104A (es) *	2011-05-09	2014-10-15	Univ Virginia Patent Found	Composiciones y metodos para el tratamiento de cancer.
BR112013029758A2 (pt)	2011-05-20	2018-10-09	Capital, Business Y Gestion De Finanzas S.L.	composição farmacêutica
EP3092027A4 (en) *	2014-01-10	2017-09-06	Atossa Genetics Inc.	Transpapillary methods and compositions for diagnosing and treating breast conditions
WO2019051416A1 (en)	2017-09-11	2019-03-14	Atossa Genetics Inc.	METHODS FOR THE MANUFACTURE AND USE OF ENDOXIFEN
AU2019274815A1 (en) *	2018-05-24	2021-01-21	Shivanka Research LLC	Prodrugs of fulvestrant
US20230255974A1 (en) *	2020-02-29	2023-08-17	The University Of Vermont	Use of thyromimetics for the treatment of cancer

2000
- 2000-04-05 GB GBGB0008172.9A patent/GB0008172D0/en not_active Ceased
2001
- 2001-02-04 UA UA2002118734A patent/UA80388C2/uk unknown
- 2001-04-02 PL PL357936A patent/PL201175B1/pl unknown
- 2001-04-02 KR KR1020027013366A patent/KR100757764B1/ko active IP Right Grant
- 2001-04-02 JP JP2001572110A patent/JP2003528919A/ja active Pending
- 2001-04-02 ES ES01917289T patent/ES2248300T3/es not_active Expired - Lifetime
- 2001-04-02 CH CH01917289T patent/CH1272195H1/de unknown
- 2001-04-02 AU AU2001244372A patent/AU2001244372B2/en not_active Expired
- 2001-04-02 HU HU0300339A patent/HU230064B1/hu unknown
- 2001-04-02 CN CN01810539A patent/CN1431905A/zh active Pending
- 2001-04-02 DK DK01917289T patent/DK1272195T3/da active
- 2001-04-02 SK SK1429-2002A patent/SK287779B6/sk not_active IP Right Cessation
- 2001-04-02 AU AU4437201A patent/AU4437201A/xx active Pending
- 2001-04-02 MX MXPA02009744A patent/MXPA02009744A/es active IP Right Grant
- 2001-04-02 CA CA002403608A patent/CA2403608A1/en not_active Abandoned
- 2001-04-02 RU RU2002129355/14A patent/RU2265438C2/ru active
- 2001-04-02 BR BR0109789-0A patent/BR0109789A/pt not_active Application Discontinuation
- 2001-04-02 EP EP01917289A patent/EP1272195B1/en not_active Expired - Lifetime
- 2001-04-02 NZ NZ539603A patent/NZ539603A/en not_active IP Right Cessation
- 2001-04-02 IL IL15193201A patent/IL151932A0/xx active IP Right Grant
- 2001-04-02 EP EP05007561A patent/EP1586323A1/en not_active Withdrawn
- 2001-04-02 WO PCT/GB2001/001500 patent/WO2001074366A1/en active IP Right Grant
- 2001-04-02 EE EEP200200574A patent/EE05026B1/xx unknown
- 2001-04-02 DE DE60113975T patent/DE60113975T2/de not_active Expired - Lifetime
- 2001-04-02 US US10/240,656 patent/US20030158166A1/en not_active Abandoned
- 2001-04-02 CZ CZ20023309A patent/CZ303096B6/cs not_active IP Right Cessation
- 2001-04-02 AT AT01917289T patent/ATE306270T1/de active
2002
- 2002-09-19 ZA ZA200207538A patent/ZA200207538B/en unknown
- 2002-09-25 IL IL151932A patent/IL151932A/en unknown
- 2002-10-01 IS IS6576A patent/IS2869B/is unknown
- 2002-10-02 NO NO20024735A patent/NO329949B1/no not_active IP Right Cessation
2003
- 2003-05-27 HK HK03103770A patent/HK1051498A1/xx not_active IP Right Cessation
2010
- 2010-09-30 US US12/895,369 patent/US20110183949A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20030007501A (ko)	2003-01-23
JP2003528919A (ja)	2003-09-30
BR0109789A (pt)	2003-01-21
RU2265438C2 (ru)	2005-12-10
NO329949B1 (no)	2011-01-31
IL151932A0 (en)	2003-04-10
GB0008172D0 (en)	2000-05-24
NO20024735D0 (no)	2002-10-02
CA2403608A1 (en)	2001-10-11
HUP0300339A2 (hu)	2003-06-28
KR100757764B1 (ko)	2007-09-12
ZA200207538B (en)	2003-12-19
IL151932A (en)	2007-07-04
NO20024735L (no)	2002-11-27
UA80388C2 (en)	2007-09-25
PL357936A1 (en)	2004-08-09
EE05026B1 (et)	2008-06-16
DE60113975D1 (de)	2006-02-23
ES2248300T3 (es)	2006-03-16
HU230064B1 (hu)	2015-06-29
EE200200574A (et)	2004-04-15
US20110183949A1 (en)	2011-07-28
CH1272195H1 (es)	2019-10-15
EP1272195B1 (en)	2005-10-12
NZ539603A (en)	2008-02-29
ATE306270T1 (de)	2005-10-15
EP1586323A1 (en)	2005-10-19
CZ303096B6 (cs)	2012-04-04
SK287779B6 (sk)	2011-09-05
EP1272195A1 (en)	2003-01-08
AU4437201A (en)	2001-10-15
IS2869B (is)	2014-03-15
DE60113975T2 (de)	2006-06-22
IS6576A (is)	2002-10-01
HUP0300339A3 (en)	2009-01-28
WO2001074366A1 (en)	2001-10-11
AU2001244372B2 (en)	2006-02-16
HK1051498A1 (en)	2003-08-08
MXPA02009744A (es)	2004-02-26
CZ20023309A3 (cs)	2003-02-12
US20030158166A1 (en)	2003-08-21
CN1431905A (zh)	2003-07-23
SK14292002A3 (sk)	2003-08-05
PL201175B1 (pl)	2009-03-31

Publication	Publication Date	Title
KR970704430A (ko)	1997-09-06	전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
DE60138611D1 (de)	2009-06-18	Synergistische kombinationstherapie zur krebsbehandlung
DK1083889T3 (da)	2004-04-13	Tetrahydronaphthalenforbindelser og deres anvendelse til behandling af neurodegenerative sygdomme
DK1382340T3 (da)	2006-08-14	Terapeutiske anvendelser af dehydroepiandrosteron til behandling af reduceret libido og osteoporose
EE200100480A (et)	2002-12-16	Ksenoon kasutamiseks närvimürgistuste ravis
DK1446012T3 (da)	2013-10-14	Bakteriolytisk kombinationsterapi til behandling af tumorer
DK1039912T3 (da)	2002-10-28	Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DE602004023342D1 (de)	2009-11-12	Siliconzusammensetzung und diese enthaltendes Papierbehandlungsmittel
DK1272195T3 (da)	2006-01-16	Anvendelse af fulvestrant til behandling af resistent brystcancer
ATE414512T1 (de)	2008-12-15	Kombinationstherapie zur behandlung von krebs
DK1716853T3 (da)	2011-06-27	Behandling af cancer i menneskekroppen ved anvendelse af ET743
DK1432417T3 (da)	2008-06-16	Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer
MXPA03008582A (es)	2003-12-08	Agentes y metodos para tratamiento de cancer.
DE60223576D1 (de)	2007-12-27	Hautbehandlungszusammensetzung
NO20053626L (no)	2005-08-26	Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
NO20033123D0 (no)	2003-07-08	Terapeutisk hinnedannende sammensetning og behandlingsplan derav
EE200200479A (et)	2003-12-15	Eksemestaani kasutamine rinnavähi ravis
NO20005548L (no)	2000-12-04	Mykobakterieinhibitorer
DK1165184T3 (da)	2004-04-13	Estrogenreceptor-beta antagonisme og knoglesygdomme
NO20010630D0 (no)	2001-02-06	Krummet trapp og trappetrinn for krummet trapp
ATE297745T1 (de)	2005-07-15	Chemische modifizierung von harn von säugern
DK199900375U3 (da)	1999-11-26	Fod og håndbademiddel
DK1379242T3 (da)	2012-09-17	Fremgangsmåde til behandling af cancer og sammensætninger til anvendelse derved
IT1314372B1 (it)	2002-12-13	Procedimento e dispositivo elettronico per il trattamento dellaceramica per protesi dentale e/o similari.
SI1272195T1 (sl)	2006-02-28	Uporaba fulvestranta pri zdravljenju rezistentnega raka dojk